Seeking Alpha

Managing

Managing
Send Message
View as an RSS Feed
View Managing's Comments BY TICKER:
Latest  |  Highest rated
  • Assessing The Beginnings Of The Orexigen Launch Of Contrave [View article]
    What I like about where we are now is that all that really matters is sales. Not efficacy, not labels, etc.
    Dec 11, 2014. 01:56 PM | 1 Like Like |Link to Comment
  • Understanding How Amazon's Use Of Capital Leases Overstates Its Cash Flow Metrics [View article]
    Lord what a perfect example of people talking up their own book to justify their own preconcieved opinions. My advice Slim is to strap on the big boy pants and actually analyze cash flow the way the pros do in the commercial banks that actually lend real money and have far more skin in the game than any of us. Pros use the UCA approach to cash flow and convert the accrual income statement into a cash flow statement by using the actual changes in the balance sheet (oversimplified). They do not use the sources and uses cash flow statement. To understand any companies cash flow you need to be able to explain the differences in cash on the balance sheet from year to year. This approach reconciles cash between periods.

    I noticed that cash and marketable securities grew by $999MM last year and is down <$5.5Bn> YTD. If you can tell me why, then I would give your analysis more weight.

    Captial leases are just that; capitalized on the balance sheet as LT debt and are treated no differently. Nothing nefarious there. You made that value judgement. It is perfectly understandable to amortize the cost of servers over three years, rather than expensing them as you suggest. Your understanding of capital leases and cash flow is limited at best and as others have pointed, you suggest deception here. You are flat out wrong.

    I call that the CFO doing their job. I am sorry that you feel inconvenienced to look up critical cash flow info in the footnotes, but the books are prepared according to Hoyle. Any banker worth his/her salt ALL READ financials the same way: backwards. Why? because all the good stuff is in there.

    BTW, smart borrowers are loading up on debt because they understand that the opportunity to borrow at these rates is a seminal moment and not likely to return any time soon. Why? because in case you didn't notice, we have been fighting deflation since the crash causing rates to sink to historical lows. Now that the US is producing just over 9MM of barrels of oil a day and OPEC is basically on life support, if we are going to get inflation, we will start to see it next year fueled by low energy costs. It is no accident that AMZN has a shelf filing out there for more debt. The real question is: Is AMZN spending wisely?

    For the record, I have no dog in this fight; have no special relationship with the company, but when I hear people like Steve Ballmer say "AMZN can't make a profit" and "doesn't generate cash flow" it makes me wonder what statements they are looking at and if they know how to read them.
    Dec 11, 2014. 11:00 AM | 1 Like Like |Link to Comment
  • How Will Marijuana Stocks React To Election Results In Alaska And Oregon? [View article]
    What an awesome list of losers Econ Student. Hopefully, someone was insightful enough to day trade a few of the stocks mentioned in the article and dump them the day after the election.
    Dec 3, 2014. 10:59 AM | Likes Like |Link to Comment
  • National News Coverage for KannaLife Sciences, Inc. an MJNA Portfolio Company [View article]
    The awkward attempt to align themselves with the NFL is pathetic.
    Dec 3, 2014. 10:00 AM | Likes Like |Link to Comment
  • AcelRx Pharmaceuticals Receives CE Mark Approval for Zalviso [View article]
    A bullish sign.
    Dec 3, 2014. 09:57 AM | Likes Like |Link to Comment
  • National News Coverage for KannaLife Sciences, Inc. an MJNA Portfolio Company [View article]
    Pot cures CTE! Yea!!!!!!!
    Dec 2, 2014. 12:27 PM | Likes Like |Link to Comment
  • Medical Marijuana Inc. Announces Third Quarter 2014 Shareholders Report [View article]
    You can tell that things are not good when the release is all about marketing events and not the numbers.
    Nov 20, 2014. 08:49 PM | Likes Like |Link to Comment
  • Arena And Vivus Investors Need To Watch Orexigen [View article]
    I hope the Shorts take it in the shorts on this one. I have never seen a stock so beaten down in the face of increasingly positive news this year. Their is a lot of borrowed stock out there and stock prices for all three VVUS, ARNA and OREX will be driven by actual script revenue. At last we can dispense with this noise around labeling, effectiveness and insurance requirements. Best sales wins. Period.
    Nov 12, 2014. 02:55 PM | Likes Like |Link to Comment
  • Lack Of Professionalism At Medical Marijuana, Inc. [View instapost]
    Perry's professionalism is about what you would expect from this sleazy outfit.
    Nov 7, 2014. 10:33 AM | 1 Like Like |Link to Comment
  • Orexigen On A Tear - In The Wrong Direction [View article]
    maceuro:

    My unsolicited insights to the 47 pages of prescription information.


    Belviq 11 pages: Long
    Actos 42 pages: Longer
    Contrave 47 pages: Longest

    Obviously if you compare font and exhibit sizes, then Belviq is by far the best drug on the market. 31 pages better than its nearest rival! Seriously dude.

    Bottom Line: Either Contrave sells or it doesn't. That will ultimately drive the stock price once the shorts are flushed out. The relevant number now is the size of the marketing force and the launch date.
    Oct 7, 2014. 03:06 PM | 1 Like Like |Link to Comment
  • Advanced Cell Technology's Turnaround Has Near-Term Catalysts [View article]
    I really want to believe in regenerative medicine using stem cells. I see an enormous opportunity. Especially in more mundane applications like regrowing cartlidge in joints such as knees and hips.

    Rock star scientist. "Gold standard" of embryonic stem cells. What could go wrong?
    Oct 6, 2014. 06:27 PM | 1 Like Like |Link to Comment
  • Medical Marijuana Inc. Announces Second Quarter 2014 Shareholders Report: 20% Growth Quarter-to-Quarter [View article]
    Some of you may have seen the fraud cases pending that I posted. Buyer beware.
    Oct 3, 2014. 08:26 PM | Likes Like |Link to Comment
  • Amazon's CEO Believes In India's Growth Story [View article]
    Given AMZN's business model, why would you NOT want to invest heavily in India who has the 2nd largest population on the planet?

    I got no dog in this fight, but......
    "It will be Jeff's Waterloo." More blather from the shorts. Stick to the fact that AMZN doesn't make any money; you'd at least sound smarter.
    Oct 1, 2014. 11:21 AM | 2 Likes Like |Link to Comment
  • First Internet Bancorp: Record Revenue And Net Income Are In Sight [View article]
    Two questions: Are they buying deposits?

    What kinds of loans are they making?

    5.Provision for loan losses was assumed to be $100,000 for both Q3 and Q4. This brings total provision in second half to be almost 3x the $74,000 provision in 1H14. This is likely a reasonable assumption, considering the constantly-improving asset quality.


    Maybe, maybe not. Banks are falling over themselves to lend money.
    Sep 29, 2014. 02:32 PM | 1 Like Like |Link to Comment
  • Orexigen's Contrave Approved: What It Means To Arena [View article]
    Wow! The conviction of the shorts is strong, was not the drug approved? I don't see a 10-bagger here but the "winner" will come from executing on the business model, not the side effects of the drug. I smell fear.
    Sep 12, 2014. 10:35 AM | Likes Like |Link to Comment
COMMENTS STATS
275 Comments
293 Likes